U.K. authorizes Johnson & Johnson COVID-19 vaccine

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

United Kingdom health regulators on Friday authorized the Johnson & Johnson vaccine for people 18 and older.

Why it matters: The J&J is the fourth vaccine to receive approval in the U.K., which has experienced one of the world's best vaccine rollouts. 58% of people in the U.K. have received at least one dose of a COVID-19 vaccine, while 36% are fully vaccinated, according to Bloomberg's tracker.

Get market news worthy of your time with Axios Markets. Subscribe for free.

  • Unlike the other shots that have been authorized — Pfizer-BioNTech, AstraZeneca and Moderna — the J&J vaccine only requires one dose.

  • U.K. health regulators said the vaccine was found to be 67% effective in preventing infection and 85% effective in preventing serious cases and hospitalizations, AP notes.

The big picture: British Prime Minister Boris Johnson warned on Thursday that a contagious coronavirus variant first identified in India is beginning to spread rapidly.

  • Public Health England on Thursday reported almost 7,000 cases of the variant, up from the over 3,500 cases reported the week prior, per Reuters.

  • The rise in infections could threaten England's final stage of reopening — originally scheduled for June 21, Reuters reports.

Go deeper: Former Boris Johnson aide gives scathing testimony on U.K.'s early COVID response

Like this article? Get more from Axios and subscribe to Axios Markets for free.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting